AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Growth_hormone

    MGF (Mechano Growth Factor) (5mg)

    Intramuscular (locally into the target muscle)2–3 times weekly5mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    Research-only — Mechano Growth Factor

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Research-only — no FDA/EMA approval
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Research monograph

    See the full MGF encyclopedia page with mechanism, evidence tier, related variants and research context.

    Open monograph
    Free Access

    How It Works

    MGF is a splice variant of IGF-1 produced locally after mechanical stress. It activates muscle satellite cells—the stem cells for muscle regeneration. These proliferate, fuse with existing muscle fibers, and donate nuclei, increasing the potential for protein synthesis and muscle hypertrophy.

    Quick Start

    • Reconstitution: Add 2.5 mL of 0.6% acetic acid → 2.0 mg/mL. ⚠️ Acetic acid only — similar structure to IGF-1, does not dissolve properly in BAC water.
    • Typical Dose: 200–400 mcg per injection, 2–3 times/wk.
    • Storage: Lyophilized: −20 °C· reconstituted: 2–8 °C, use within 7–10 days.
    Detailed Protocol Data

    Typical Protocol (2.5 mL = 2.0 mg/mL)

    Educational only
    Vial Size— affects syringe units
    BAC Water2.5 mL
    Concentration2.00 mg/mL

    Route: Intramuscular (locally into the target muscle) | Frequency: 2–3 times weekly

    WeekDoseUnits (per injection)
    Weeks 1–2
    200 mcg
    10 Units (0.10 mL)
    Weeks 3–4
    300 mcg
    15 Units (0.15 mL)
    Weeks 5+
    400 mcg
    20 Units (0.20 mL)

    Studies report intramuscular administration in close temporal proximity to exercise, localized to the muscle under study. MGF has a very short half-life (~minutes) — the PEGylated form (PEG-MGF) lasts longer.

    Related compounds

    Reconstitution Steps

    1. ⚠️ Use 0.6% acetic acid exclusively — NOT bacteriostatic water. MGF has a hydrophobic structure similar to IGF-1.
    2. Withdraw 2.5 mL of 0.6% acetic acid.
    3. Slowly inject against the side wall; avoid foaming.
    4. Gently swirl until fully dissolved.
    5. Refrigerate at 2–8 °C; use within 7–10 days (sensitive peptide).

    Protocol Overview

    • Goal: Local muscle growth and repair post-workout/injury.
    • Schedule: 2–3 IM injections weekly for 4–8 weeks.

    Dosing Protocol

    • Start: 200 mcg × 2/wk.
    • Titration: 300–400 mcg if well-tolerated.
    • Timing: Immediately post-workout into the target muscle.
    • Cycle: 4–8 weeks.
    • Break between cycles: After the cycle (4–8 weeks), a 4–6 week washout period is recommended. The break prevents desensitization of IGF-1 receptors.

    Washout & Cycle Restart

    When can I restart?

    After the cycle (4–8 weeks), a 4–6 week washout period is recommended. The break prevents desensitization of IGF-1 receptors.

    Minimum wait period: 4 weeks

    Storage Instructions

    • Lyophilized: −20 °C.
    • Reconstituted: 2–8 °C; use within 7–10 days (sensitive peptide).
    • Do not freeze the reconstituted solution.

    Important Notes

    • Standard MGF has a very short half-life (~minutes).
    • Inject IM locally into the target muscle immediately after exercise.
    • The PEG-MGF form has an extended duration of action (~hours).
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Muscle Hypertrophy: Activation of satellite cells.
    • Repair: Faster regeneration after injury.
    • Local Action: Targeted growth in the injected muscle.
    • Synergy: Can be combined with IGF-1 LR3 or GH peptides.

    Potential Side Effects:

    • Generally very well-tolerated.
    • Mild injection site irritation.
    • Theoretical concern for hypoglycemia at very high doses.

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    🎗️ Cancer Markers
    🟡 Moderate / Theoretical

    Mechano Growth Factor — potential oncogenesis

    MGF (IGF-1 Ec splice variant) promotes muscle hypertrophy and cell proliferation. Theoretical concern for enhancing neoplasms — especially in tissues with active mitosis.

    📄 Growth Horm IGF Res 2004

    References

    1. Endocrine Reviews (2005) — IGF-I splice variants and the role of MGF
      View Source
    2. J Applied Physiology (2003) — MGF expression in human muscle
      View Source
    3. Growth Hormone & IGF Research (2004) — MGF and muscle repair
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    0
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    Research peptide — No regulatory approval from any agency

    Research-only — Mechano Growth Factor

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu